Results 71 to 80 of about 3,238 (182)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Discover Oncology
Background and purpose The role of local ablative radiotherapy (stereotactic body radiotherapy (SBRT)/stereotactic radiosurgery (SRS)) in the management of metastatic breast cancer (mBC) patients remains unclear.
Xiaomin Li, Yu Sun, Liang Tang, Yan Li, Xiaoqin Yang   +4 more
doaj   +1 more source

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview

Frontiers in Oncology, 2019
The oligometastatic state is hypothesized to represent an intermediary state of cancer between widely metastatic disease and curable, localized disease.
Kang Liang Zeng, Chia-Lin Tseng, Hany Soliman, Yonatan Weiss, Arjun Sahgal, Sten Myrehaug   +5 more
doaj   +1 more source

Acute Intestinal Obstruction Caused by Dual‐Component Metastasis From Combined Small Cell Lung Cancer: A Rare Case and Literature Review

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT This case report describes a 75‐year‐old male patient who was admitted due to acute intestinal obstruction. The patient had a history of small cell lung cancer. Emergency surgery pathology confirmed the presence of primary composite small cell lung cancer with rare independent dual component metastasis: The colonic lesion was metastatic poorly
Wei Jiang, Xiaohui Zhou, Xizhang Zhu
wiley   +1 more source

Stereotactic body radiation therapy on abdominal-pelvic lymph node oligometastases: a systematic review on toxicity

Acta Oncologica
Background and purpose: To review available data on toxicity during and/or after treatment of abdominal-pelvic lymph node oligometastases (A-P LN) with stereotactic body radiation therapy (SBRT) and to provide an overview of adverse events and its ...
Lucy A. van Werkhoven, Eugenio Cammareri, Mischa S. Hoogeman, Remi A. Nout, Maaike T.W. Milder, Joost J.M.E. Nuyttens   +5 more
doaj   +1 more source

Beyond Oligometastases [PDF]

International Journal of Radiation Oncology*Biology*Physics, 2020
David A, Palma, Glenn S, Bauman, George B, Rodrigues   +2 more
openaire   +2 more sources

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, Volume 2, Issue 1, Page 157-180, March 2026.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source

Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel

Cancer, Volume 132, Issue 4, 15 February 2026.
Abstract Background The expansion of treatment options for prostate cancer (PC) has improved disease‐specific and overall survival outcomes but has also raised questions about the optimal level of treatment needed for patients based on their individual prognosis and accounting for potential toxicity, incorporating quality of life considerations ...
Rana R. McKay, Benjamin L. Maughan, Alicia K. Morgans, Neal D. Shore, Evan Y. Yu, Ravi A. Madan, Jacob E. Berchuck, Bradley C. Carthon, Steven E. Finkelstein, Leonard Gomella, Michael A. Gorin, Andrew W. Hahn, Stacy Loeb, Vivek K. Narayan, Daniel P. Petrylak, Charles J. Ryan, Karine Tawagi, Phuoc T. Tran, Tanya Dorff   +18 more
wiley   +1 more source

Bone Metastasis: Molecular Mechanisms, Clinical Management, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
This figure emphasizes current understanding of the regulatory networks, approach of diagnose, available preclinical models and clinical management of bone metastasis. to guide future therapeutic development. A deep understanding of these aspects enables the prevention of bone metastasis and the implementation of effective therapeutic strategies ...
Jingyuan Wen, Binghua Li, Shengjia Wang, Yongzhong Yao, Zhao Huang, Decai Yu   +5 more
wiley   +1 more source

PSMA PET‐directed radiotherapy for prostate cancer: From precision planning to future innovations

VIEW, Volume 7, Issue 1, February 2026.
Prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) imaging enables highly sensitive detection of prostate cancer recurrence and precise lesion mapping. This review summarizes current evidence and emerging applications of PSMA PET in radiotherapy, including diagnostic staging, target delineation, adaptive planning, and outcome ...
Wenpeng Huang, Jessica C. Hsu, Ruobing Li, Kexin Lan, Xin Qi, Yuchun Wei, Weibo Cai, Hongzhen Li   +7 more
wiley   +1 more source

Clinical experience with a same‐day simulation and treatment program for stereotactic radiation therapy on a C‐arm linac

Journal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Purpose We report our experience with the implementation of a same‐day simulation and treatment C‐arm linear accelerator (linac)‐based stereotactic program for patients with intracranial and extracranial metastatic disease. Methods Between May 2021 and October 2023, patients were treated in our same‐day program with linac‐based SRS/SBRT.
Michalis Aristophanous, Sernger Shen, Dylan G. Hsu, Dongxu Wang, Ase Ballangrud, Jean M. Moran, Anyi Li, Sean M. McBride, Daniel Gomez, Luke R. G. Pike, Kathryn Beal, Jonathan T. Yang, Laura Cervino   +12 more
wiley   +1 more source